Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 53, pseudogene (GPR53P) is annotated as a pseudogene in the human genome, located on chromosome 6p22.1, and has synonyms including PsiGPR53 and dJ271M21.8[2][5][8]. Pseudogenes are DNA sequences similar to known genes but that have lost their protein-coding ability or are otherwise nonfunctional; as such, GPR53P does not encode a functional receptor protein and is not considered a therapeutic drug target[2][5][8]. There are no documented biological functions, disease associations, or drug interactions for this pseudogene. Canonical status and function: GPR53P is classified as a pseudogene, according to major gene annotation sources[2][5][8]. This means it is a remnant of a gene related to G protein-coupled receptors, but does not encode a functional protein. Therapeutic target status: Because it is a pseudogene, it is not considered a drug target or a functional receptor. There is no evidence of biological activity, ligand binding, or pharmacological intervention. Aliases and nomenclature: Alternative names (aliases) include PsiGPR53 and dJ271M21.8[2][5][8]. Molecular classification: While its sequence is related to G protein-coupled receptors (GPCRs)—a large family of cell-surface receptors involved in signal transduction—GPR53P itself is not a functional GPCR due to its pseudogene status. Conclusion: GPR53P ("G protein-coupled receptor 53, pseudogene") is not a functional molecule, does not have known biological roles, and is not a therapeutic target because it is a noncoding pseudogene[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 53, pseudogene (GPR53P).